JERUSALEM (JTA) — Israel has signed a deal with the American biotech company Moderna for a potential COVID-19 vaccine.
Israeli Prime Minister Benjamin Netanyahu confirmed the deal on Wednesday during a meeting of the government’s so-called Coronavirus Cabinet, Channel 12 News reported.
Netanyahu said the company claims it will have a vaccine by the middle of next year, and “we hope they will succeed.” Securing a deal to buy the future vaccine “puts us in a very good place in the world.” No details of the deal have been reported.
Forbes reported last week that Moderna has said that its phase 2 trials are underway and the company had enrolled 350 of a total 600 planned participants for the study.
Moderna also said that it was on track to deliver approximately 500 million doses of the vaccine per year and potentially up to 1 billion annually starting in 2021.
Israeli efforts to develop a vaccine are ongoing, Netanyahu said.
The Institute for Biological Research in Nes Ziona, in central Israel, last month completed a successful trial on rodents, according to Channel 12, and will soon begin trials on larger animals.
JTA has documented Jewish history in real-time for over a century. Keep our journalism strong by joining us in supporting independent, award-winning reporting.
